- Uncontrollable stress in healthcare workers may be a legal hazard, researchers argue
- Baptist Health Richmond names chief medical officer
- 101 hospital and health system chief pharmacy officers to know | 2026
- 21 new behavioral health study findings to know
- 32 behavioral health executive moves to know
- 7 Medicaid behavioral health fraud cases, audit findings to know
- Beyond alarm management: How Elizabeth Seton Children’s Center turned surveillance data into personalized pediatric care
- What’s next for Rush’s retiring CEO
- Healthcare billing fraud: 10 recent cases
- Assort Health raises $120M
- HCA Florida hospital taps COO
- 48 recent hospital, health system executive moves
- How long does it take to sell an ASC?
- Why 34 health systems bet big on GI in 2026
- Lung cancer screening, mortality and incidence — by state
- My Community Dental Centers appoints new CEO
- 42 North Dental appoints chief marketing officer
- Physicians vs. prior authorization: 10 updates
- Physicians, not hospitals, are driving practice acquisitions: Study
- ADA backs federal healthcare workforce bill
- Standard Dental Labs plans acquisition of Florida lab
- The states where physicians earn the most after taxes
- Where 6 cardiology advocacy efforts stand now: ACC
- Leadership training, insurance, bonuses and more: What the best dental workplaces offer employees
- UM Health-Sparrow receives record gift for behavioral health hospital
- US psychiatrist workforce to meet 42.8% of projected demand by 2037: Study
- 14 new behavioral health projects to know
- What hospital-employed physicians regret most after an acquisition: Study
- Heartland Dental opens Ohio practice
- Eugene Gastroenterology Consultants opens new ASC
- CRNAs are leaving hospital jobs — where are they going?
- 5 DSOs making headlines
- 2 physicians pay $2.2M to settle claims of medically unnecessary surgical procedures
- Cancer Drug Shortage Renews Calls For Federal Action
- Next-Generation Blood Test Improves Detection Of Aggressive Prostate Cancer
- As PBM industry shifts, LucyRx and Abarca Health merge to build scale
- FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483
- Most Patients Want Docs To Break Cancer News Directly, Not Through Portal Messaging
- Sanofi under antitrust probe as European Commission kicks off formal proceedings
- Weekly Rundown: Innovaccer, AWS ink strategic collaboration; Mount Sinai adopts Signal 1 for AI management
- Industry Voices—What Pope Leo’s AI encyclical could mean for healthcare: 3 key takeaways for leaders
- Europe's CHMP reverses endorsement of Tavneos as Amgen FDA hearing looms
- Statins Rarely Cause Severe Muscle Problems, Researchers Say
- Even In Blue States, Hospitals Continue To Drop Gender-Affirming Care For Youths
- Younger U.S. Generations Increasingly Fear Adulthood, Study Says
- Opioid Settlement Money Pays For Services To Battle Addiction In Rural Kentucky
- Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know
- Efforts To End School Vaccine Mandates Hit a Wall in Florida
- Medicare Advantage Company Pays $342M to Government in Midst of Billing Probe
- Fierce Pharma Asia—Historic solid tumor CAR-T nod; Inside Pfizer, Innovent’s $10B pact; More China deals
- Eli Lilly taps AI to bring personal memories to life during its European radio show road trip
- BeOne boosts support for Blood Cancer United with $5M commitment
- Pharma’s Cannes-do attitude sees industry return to triumph
- Biogen launches ‘Ready for More’ HD Spinraza campaign with a focus on how we see SMA
- Senators revive bill targeting expanded methadone access
- DSOs gain new funding to fuel growth: 3 updates
- Montana hospital to end dental services due to financial constraints
- Rhode Island expands reimbursement options for public health hygienists
- 2 behavioral health providers to affiliate under Boundless name
- 5 states targeting Medicaid behavioral health enrollment amid fraud concerns
- Arizona behavioral health clinic suspended from Medicaid amid fraud allegations
- Cassidy's new plan to overhaul 340B: Rebates, contract pharmacy limits and more changes
- With Medicare's GLP-1 'bridge' coming soon, Walmart expands weight management supports for consumers
- Air Force Outbreak Grows As Military Reinstates Flu-Shot Rule For Recruits
- Bayer scores landmark victory as Supreme Court overturns Roundup verdict
- Democrats to propose bill capping out-of-pocket costs for Medicare enrollees
- Upside secures $20M series A to expand healthcare-focused housing platform
- GLP-1 Weight-Loss Boom Linked To Surge In Poison Control Calls
- Fosun Pharma plots global push beyond oncology, fueled by multi-asset Alzheimer’s strategy
- FDA shines harsh light on Pinnacle after finding fault with photodynamic therapy videos
- Brain Scans Improve Targeting Of Magnetic Stimulation For Depression
- Estrogen Birth Control May Protect Women’s Brains As They Age
- Very Few Men Discuss Prostate Cancer Screening With Their Doctor
- Merck KGaA throws down $11.3B for Bio-Techne in its biggest deal since 2015 Sigma-Aldrich buy
- Severe Pregnancy Nausea Tied To Higher Risk Of Complications
- A Ban Won't Stop Abortion Pill Access, Telehealth Providers Say
- Opioid Settlement Money Pays for Services To Battle Addiction in Rural Kentucky
- Democrats To Propose Bill Capping Out-of-Pocket Medicare Costs for Enrollees
- Oracle partners with Theator to expand AI-powered surgical documentation to operating rooms
- Jubilant HollisterStier gets FDA warning letter for quality control problems
- Ionis scores transformational FDA label expansion for Tryngolza
- AstraZeneca spells out a community cancer screening strategy with the YMCA
- Novartis teams up with Becoming rentABLE for its new SMA campaign
- Assort Health scores $120M series C to scale voice AI agent platform for healthcare
- Kaiser Health Plan ordered to pay hospital $82M over insufficient reimbursement
- TigerConnect expands AI-driven platform with new scheduling capabilities
- US health spending set to reach $9T by 2034: CMS report
- Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief
- Senators call for $50B rural health fund to better target small providers, relax spending restrictions
- First Stop Health expands weight management program, shares first-year results
- Florida AG to probe CVS for anticompetitive pharmacy practices
- Pfizer scores 1st expansion in 7 years for breast cancer blockbuster Ibrance
- UnitedHealth, Humana And CVS Denied Post-Hospital Care At Some Of The Highest Rates
- Infinitus launches risk detection system to ensure appropriate patient triage from AI agents
- Even 5-Minute Movement Breaks Can Boost Your Mood And Fight Fatigue
- Lilly exec says MFN will affect company's obesity pill launch strategy in Europe: report
- Stada, under new CapVest ownership, picks up horde of European consumer brands
- Belly Laughs Spring From The Primitive Brain, Researchers Say
- Mom's Good Heart Health Lowers Risk Of Baby's Developmental Delays
- Accelerated Aging May Explain Rising Cancer Risk In Young Adults
- Coval raises $28M series A to address AI voice agent reliability, compliance
- Amid safety concerns, ADC Therapeutics plots 17% staff cuts to push resources behind Zynlonta
- Racial Gaps Narrow For U.S. Cancer Deaths, Report Finds
- Medicare's AI Push Snarls Patients And Doctors In Errors And Delays
- Even in Blue States, Hospitals Have Continued To Drop Gender-Affirming Care for Youths
- Patients prefer healthcare providers' AI agents to public chatbots, with human oversight non‑negotiable, survey finds
- Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing
- Some life insurers compete with health insurers on benefits. Here's why
- DOJ announces $6.5B healthcare fraud takedown with record Medicaid enforcement
- Locum tenens coverage becoming ‘more purposeful’ staffing strategy: Definitive Healthcare
- Testosterone Therapy Labels And Limits May Change Under FDA Proposal
- Midlife Strength Training Linked to Lower Diabetes Risk
- Badges, bots and blind spots
- Patient Portal Messages Double, Doctors Face Rising Workload
- Most Americans Unaware Of Link Between Alcohol And Cancer — And Aren't Interested In Spreading The Word, Either
- Sunscreen Misinformation Popular On TikTok, Study Finds
- Indiana Takes On Powerful Hospitals By Capping Prices They Charge Employers
- Kids’ Juice And Soda Intake Linked To Higher Blood Pressure Risk As Young Adults
- Worried About Your Aging Parents? Welcome to the Caregiving Club
- Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
- AdvanCell locks in lease for US headquarters, radiopharmaceutical production near Boston
- Clover Hill Dairy Recalls All Cheese in Deadly Listeria Outbreak
- Middle-Aged Women Drink More, Know Less About Breast Cancer Risk
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- High Hurdles Thwart Kidney Patients' Pursuit Of Life-Saving Transplants
- Rising Healthcare Costs Leave Many Americans Less Secure
- Short Videos Help First-Time Dads Learn Newborn Safety Basics
- Federal Push To Increase U.S. Primary Care Docs Has Fizzled, Study Says
- They're Uninsured After Obamacare Became Too Costly. And They're Far From Alone.
- Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
Michigan healthcare freedom community forum
Michigan Medicine is seeking individuals who have recently been diagnosed with cancer, or who have a family history of cancer. Researchers are creating a genetic library to identify markers which correlate with a variety of cancers:
MiGHT (Michigan Genetic Hereditary Testing) StudyReducing Cancer’s Impact through Genetic Testing
What is MiGHT?
The MiGHT (Michigan Genetic Hereditary Testing) Study is a statewide effort to better identify and care for individuals and families with inherited risk of cancer.
We are testing ways to:
* Improve family history collection by healthcare providers
* Guide people through the process of genetic testingAbout the study
Testing for inherited susceptibility to cancer has been available for over 20 years, but uptake remains low among even patients at high risk. It is now well-established that between 1 in 5 and 1 in 20 patients with breast, ovarian, endometrial or colorectal cancers has a deleterious germline mutation conferring inherited susceptibility to cancer.
Despite advances in genetic testing technologies and a decrease in the cost of testing, the uptake of testing among eligible patients with cancer remains unacceptably low. There is thus a gap between actual and ideal care with implications for primary and secondary cancer prevention and treatment in people with an inherited susceptibility and their family members.
The MiGHT study leverages diverse, statewide partnerships among healthcare and public health entities to employ both practice- and patient-level interventions to improve family history collection and uptake of genetic testing, with the overarching goal of reducing cancer morbidity and mortality.
Why is a family health history helpful? What information do I need?
Family history is often the first clue that a hereditary cancer condition is running in the family. The most important pieces of information are (1) the specific types of cancer in your relatives and (2) ages of diagnosis. Most cancers do not have a hereditary cause, but knowing your family history can help your healthcare provider determine if you might benefit from genetic testing, inform your treatment decisions, and ultimately take better care of you and your family.
How do I access the Family History Survey?
There are two ways to access our family cancer history survey.
1. If you are a patient at an oncology practice in the state of Michigan that participates in the Michigan Oncology Quality Consortium (MOQC), you may receive an email or text notification from your provider with a link and unique access code to take the survey in advance of your appointment.
2. If you aren’t sure if your oncology clinician participates in MOQC, or you haven’t personally been diagnosed with cancer but have family members who have, and you would like to use our secure survey to document and share your family’s cancer history, then you can get started on your own. To begin documenting your family’s cancer history register yourself today.
You can access the survey on any device with an internet connection, such as your computer, tablet, or mobile phone. All internet browsers are supported. Once you’ve submitted your responses, you will be able to save or print a pdf of your report to share with loved ones and trusted healthcare providers.
How long does it take to complete the survey?
The time it takes depends on the size of your family and the number of cancers. The survey takes most people less than 20 minutes. It may take some time to gather the information needed to answer the survey questions (for example the cancer types or ages of relatives).
How do I save information? Can I stop and go back in later?
Your survey responses will automatically save. You can close out of the survey and go back in at any time and the survey will pick up where you left off until you submit your final answers.
I don’t know the answers to some of the questions—what should I do?
It is OK if you do not know all the information! Most questions have a “do not know” or skip option. However, the more information you can find out, the more accurate your results will be, so please make your best estimate whenever possible. Any information you have will be helpful.
Is my information private?
We are committed to your privacy. Unless you give the MiGHT study team permission, only you, the operators of the MiGHT database, and your healthcare provider – if asked to complete the survey by your provider – will have access to your survey results. Your information will be protected by the privacy policies of your healthcare provider and Michigan Medicine. For more information see http://www.uofmhealth.org/patient+and+visitor+guide/hipaa.
Can I get a copy of my results?
Yes, at the end of the survey you will be able to print your results. These results contain personal health information about you and your relatives. If you choose to share your results we recommend you take reasonable precautions. For example, you might encrypt the information before sending it over email.
What do my results mean?
The survey tool does not provide medical advice. The information collected will be useful when discussing with your healthcare provider. In some cases, your provider may recommend further genetic evaluation.
Have more questions?
Contact our team at might@moqc.org
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















